NCT00000876 - Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2006

Conditions

HIV Infections

Interventions

DRUG

CD4-IgG2

Trial Locations (8)

Univ. of Florida Jacksonville NICHD CRS, Jacksonville

Texas Children's Hosp. CRS, Houston

Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach

Children's Hosp. of Orange County, Orange

Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy, Los Angeles

UCSF Pediatric AIDS CRS, San Francisco

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles

Children's National Med. Ctr. Washington DC NICHD CRS, Washington D.C.

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH